NCT06001658 2025-12-03
Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Recruiting
Clinical Trials
10 trialsNCT02539537 2024-01-09
NEOPAN
UNICANCER
Phase 3 Completed
NCT03611556 2023-10-03
MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study.
MedImmune LLC
Phase 1/2 Completed
NCT01431794 2020-01-22
Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1/2 Terminated
NCT01088815 2019-04-26
Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT01469598 2015-12-29
Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell Cancer
Samsung Medical Center
Phase 2 Completed
NCT01019382 2014-12-04
A Study of the Effect of Gemcitabine With Fish Oil in Patients With Advanced Pancreatic Cancer
University Hospitals, Leicester
Phase 2 Completed
NCT00401570 2013-01-30
A Study of Volociximab in Combination With Gemcitabine in Metastatic Pancreatic Cancer
AbbVie
Phase 2 Completed
NCT00192712 2010-11-10
Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic Cancer
Rambam Health Care Campus
Phase 2/3 Completed
NCT00192842 2010-09-22
Gemcitabine With Curcumin for Pancreatic Cancer
Rambam Health Care Campus
Phase 2 Completed